- Home
- GOOD vs ORGO Comparison
GOOD vs ORGO Comparison
Compare GOOD & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOOD
- ORGO
- Stock Information
- Founded
- GOOD 2003
- ORGO 1985
- Country
- GOOD United States
- ORGO United States
- Employees
- GOOD N/A
- ORGO N/A
- Industry
- GOOD Real Estate Investment Trusts
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- GOOD Real Estate
- ORGO Health Care
- Exchange
- GOOD Nasdaq
- ORGO Nasdaq
- Market Cap
- GOOD 659.5M
- ORGO 533.9M
- IPO Year
- GOOD N/A
- ORGO N/A
- Fundamental
- Price
- GOOD $14.35
- ORGO $2.74
- Analyst Decision
- GOOD Hold
- ORGO Buy
- Analyst Count
- GOOD 1
- ORGO 2
- Target Price
- GOOD $15.00
- ORGO $5.50
- AVG Volume (30 Days)
- GOOD 371.6K
- ORGO 1.7M
- Earning Date
- GOOD 05-07-2025
- ORGO 05-08-2025
- Dividend Yield
- GOOD 8.36%
- ORGO N/A
- EPS Growth
- GOOD N/A
- ORGO N/A
- EPS
- GOOD 0.30
- ORGO N/A
- Revenue
- GOOD $151,168,000.00
- ORGO $458,760,000.00
- Revenue This Year
- GOOD $4.73
- ORGO $2.73
- Revenue Next Year
- GOOD $2.84
- ORGO $12.28
- P/E Ratio
- GOOD $48.64
- ORGO N/A
- Revenue Growth
- GOOD 3.01
- ORGO 5.35
- 52 Week Low
- GOOD $12.67
- ORGO $2.28
- 52 Week High
- GOOD $17.88
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- GOOD 54.95
- ORGO 30.42
- Support Level
- GOOD $13.66
- ORGO $2.96
- Resistance Level
- GOOD $14.34
- ORGO $3.28
- Average True Range (ATR)
- GOOD 0.23
- ORGO 0.18
- MACD
- GOOD 0.04
- ORGO -0.05
- Stochastic Oscillator
- GOOD 84.15
- ORGO 2.52
About GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.